• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Regional immunotherapy in resectable squamous cell lung carcinoma. Analysis of a randomized study.可切除鳞状细胞肺癌的区域免疫治疗。一项随机研究的分析。
Cancer Immunol Immunother. 1982;13(3):174-5. doi: 10.1007/BF00205383.
2
Four-year follow-up on the Albany experience with intrapleural BCG in lung cancer.对奥尔巴尼胸膜内注射卡介苗治疗肺癌经验的四年随访。
J Thorac Cardiovasc Surg. 1981 Apr;81(4):485-92.
3
Intrapleural BCG in operable lung cancer.可手术肺癌的胸膜内卡介苗接种
Lancet. 1980 Jan 5;1(8158):11-4. doi: 10.1016/s0140-6736(80)90551-6.
4
Post-operative intrapleural BCG in lung cancer: a 5-year follow-up report.肺癌术后胸膜腔内注射卡介苗：5年随访报告
Cancer Immunol Immunother. 1986;22(2):155-9. doi: 10.1007/BF00199131.
5
A placebo-controlled randomized double-blind study of adjuvant intrapleural BCG in patients with resected T1N0, T1N1, or T2N0 squamous cell carcinoma, adenocarcinoma, or large cell carcinoma of the lung. LCSG Protocol 771.一项关于辅助性胸膜内卡介苗治疗肺T1N0、T1N1或T2N0期鳞状细胞癌、腺癌或大细胞癌患者的安慰剂对照随机双盲研究。肺癌研究组方案771。
Chest. 1994 Dec;106(6 Suppl):287S-292S.
6
Regional immunotherapy of lung cancer with intrapleural B.C.G.卡介苗胸膜腔内注射对肺癌的区域免疫治疗
Lancet. 1976 Feb 21;1(7956):377-9. doi: 10.1016/s0140-6736(76)90212-9.
7
Preliminary results of combined surgery and adjuvant Bacillus Calmette-Guérin plus levamisole treatment of resectable lung cancer.手术联合辅助卡介苗及左旋咪唑治疗可切除肺癌的初步结果
Cancer Treat Rep. 1978 Nov;62(11):1671-5.
8
BCG immunotherapy of lung cancer in a district oncology dispensary. I. Study of 860 patients with histologic diagnosis.某地区肿瘤防治所肺癌的卡介苗免疫疗法。一、860例组织学确诊患者的研究
Neoplasma. 1982;29(1):93-110.
9
Adjuvant immunotherapy of lung cancer with BCG cell wall skeleton (BCG-CWS).用卡介苗细胞壁骨架（BCG-CWS）对肺癌进行辅助免疫治疗。
Cancer. 1979 Apr;43(4):1314-9. doi: 10.1002/1097-0142(197904)43:4<1314::aid-cncr2820430420>3.0.co;2-6.
10
[Significance of immunotherapy as an adjunct to surgical treatment in non-small cell carcinoma of the lung].[免疫疗法作为肺癌非小细胞癌手术治疗辅助手段的意义]
Gan To Kagaku Ryoho. 1985 Jan;12(1):13-20.

引用本文的文献

1
Assays for predicting and monitoring responses to lung cancer immunotherapy.预测和监测肺癌免疫治疗反应的检测方法。
Cancer Biol Med. 2015 Jun;12(2):87-95. doi: 10.7497/j.issn.2095-3941.2015.0019.
2
Post-operative intrapleural BCG in lung cancer: a 5-year follow-up report.肺癌术后胸膜腔内注射卡介苗：5年随访报告
Cancer Immunol Immunother. 1986;22(2):155-9. doi: 10.1007/BF00199131.

本文引用的文献

1
Adjuvant immunotherapy with BCG in squamous cell bronchial carcinoma.卡介苗辅助免疫疗法治疗支气管鳞状细胞癌。
Thorax. 1980 Oct;35(10):781-7. doi: 10.1136/thx.35.10.781.
2
Intrapleural BCG in operable lung cancer.可手术肺癌的胸膜内卡介苗接种
Lancet. 1980 Jan 5;1(8158):11-4. doi: 10.1016/s0140-6736(80)90551-6.
3
Regional immunotherapy with intrapleural BCG for lung cancer.卡介苗胸膜腔内注射区域免疫疗法治疗肺癌
J Thorac Cardiovasc Surg. 1976 Sep;72(3):333-8.
4
Preliminary results of combined surgery and adjuvant Bacillus Calmette-Guérin plus levamisole treatment of resectable lung cancer.手术联合辅助卡介苗及左旋咪唑治疗可切除肺癌的初步结果
Cancer Treat Rep. 1978 Nov;62(11):1671-5.

可切除鳞状细胞肺癌的区域免疫治疗。一项随机研究的分析。

Regional immunotherapy in resectable squamous cell lung carcinoma. Analysis of a randomized study.

作者信息

Roeslin N, Lang J M, Morand G, Wihlm J M, Witz J P

出版信息

Cancer Immunol Immunother. 1982;13(3):174-5. doi: 10.1007/BF00205383.

DOI:10.1007/BF00205383
PMID:6925982
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11039180/
Abstract

Patients with resectable squamous cell carcinoma were randomly allocated after surgery to receive either no further treatment (57 patients) or a single intrapleural injection of BCG (61 patients). No significant improvement in survival was observed in patients treated with BCG, even when their disease was staged as N0. There was a slight trend for the recurrence rate to be lower in patients classed as N0, but this was not significant.

摘要

可切除的鳞状细胞癌患者在手术后被随机分配，要么不接受进一步治疗（57例患者），要么接受单次胸膜内注射卡介苗（61例患者）。即使疾病分期为N0，接受卡介苗治疗的患者在生存率方面也未观察到显著改善。被归类为N0的患者复发率有轻微降低趋势，但并不显著。